Enterome strengthens its leadership team with the appointment of Anne Dagallier as Chief Business Officer prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
QIAGEN N.V.: QIAGEN Announces 20-F Annual Report Filing for 2020 Results
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2020, with the U.S. Securities and Exchange Commission. The document can be accessed on QIAGEN s website at https://corporate.qiagen.com/investor-relations/financial-reports
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation soluti
US private capital funds must invest US$3 billion over next five years to meet investors increasing demands for transparency, Intertrust Group says
- 70% of CFOs at US private capital funds expect their investors to demand live or daily updates on portfolio performance and cybersecurity
- Intertrust Group estimates US$5.5 billion will be needed globally
News provided by
Share this article
in the United States
face growing demands for transparency as mainstream investors increasingly turn to the sector to chase the higher returns it offers, new research from Intertrust N.V. ( Intertrust Group or Company ) [Euronext: INTER] reveals. Intertrust Group, a world leader in providing specialized administration services to clients in over 30 jurisdictions, estimates that around US$3 billion will need to be spent in the US alone to meet these increasing demands over the next five years. The estimated cost for the private capital funds industry globally is US$5.5 billion.
PARIS, Feb. 10, 2021 /PRNewswire/ ENTEROME SA, a clinical-stage biopharmaceutical company focused on the discovery and development of novel microbiome driven therapeutics based on the unrivalled